You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • SAT0221 Efficacy and Safety of PF-04171327, a Novel Dissociated Agonist of the Glucocorticoid Receptor (DAGR): Results of a Phase 2, Randomized, Double-Blind Study

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - non biologic treatment and small molecules
SAT0221 Efficacy and Safety of PF-04171327, a Novel Dissociated Agonist of the Glucocorticoid Receptor (DAGR): Results of a Phase 2, Randomized, Double-Blind Study

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 20152601
Jul 2015400
Aug 2015901
Sep 20152202
Oct 20151004
Nov 20151802
Dec 20152801
Jan 20162802
Feb 20163002
Mar 20163202
Apr 20161200
May 20162503
Jun 20163501
Jul 20162901
Aug 20161200
Sep 2016702
Oct 201622028
Nov 20161703
Dec 20161001
Jan 20172202
Feb 20172905
Mar 20173705
Apr 20172107
May 20171804
Jun 20172206
Jul 20173403
Aug 20176002
Sep 20174606
Oct 20171000
Nov 20172401
Dec 2017800
Jan 20183800
Feb 20182003
Mar 20183200
Apr 2018200
May 20181000
Jun 20181201
Jul 20181000
Aug 20181200
Sep 2018802
Oct 2018400
Nov 2018400
Dec 20181400
Jan 2019400
Feb 2019600
Mar 20191801
Apr 2019801
May 20192501
Jun 2019802
Jul 2019200
Aug 2019400
Sep 20191100
Oct 2019300
Nov 20191101
Dec 2019700
Feb 2020801
Mar 20201000
Apr 2020901
May 20201000
Jun 20202800
Jul 2020800
Sep 20202100
Oct 20201000
Nov 20201300
Dec 2020400
Jan 2021500
Feb 2021200
Mar 2021200
Apr 2021300
Jun 2021500
Oct 2021800
Nov 20211000
Dec 20211000
Jan 20221100
Feb 2022600
Mar 2022300
Apr 20221700
May 20221100
Jun 2022200
Jul 20221100
Aug 20221001
Sep 2022900
Oct 2022800
Nov 20222002
Dec 20221000
Jan 20232700
Feb 2023700
Mar 20231600
Apr 2023600
May 2023200
Jun 2023700
Jul 2023500
Aug 2023400
Sep 20231200
Oct 2023300
Nov 2023500
Dec 2023600
Jan 20241100
Feb 2024200
Mar 2024600
Total13830114